Stock-Based Compensation

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and nine months ended September 30, 2016 and 2015, was as follows:



	Three Months Ended				September Months Ended
	September 30,				September 30,
	2016		2015		2016		2015
Cost of goods sold	$	200	$	257	$	730	$	731
Operating expenses:
Research and development	389		252		1,187		737
Clinical and regulatory affairs	290		321		782		749
Marketing and sales	1,004		888		3,395		2,476
General and administrative	992		832		3,547		2,476
Total operating expenses	$	2,675	$	2,293	$	8,911	$	6,438
Total	$	2,875	$	2,550	$	9,641	$	7,169

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details